Sort by 
AstraZeneca and Roche Diagnostics Asia Pacific sign MOU to advance AI pathology in breast and lung cancer
AstraZeneca and Roche Diagnostics Asia Pacific have signed a three-year memorandum of understanding to advance AI-powered digital pathology capabilities and improve biomarker testing in breast and lung cancer across nine Asian markets.
Channelle Pharma partners with SAP to advance digital manufacturing transformation
Irish pharmaceutical company Channelle Pharma has announced a strategic partnership with SAP to implement SAP S/4HANA Cloud and SAP Business AI, modernising its end-to-end operational value chain across its international operations.
Almac Group delivers record revenue and profit in landmark year for Craigavon pharma giant
Craigavon-headquartered pharmaceutical organisation Almac Group has posted record revenues of £1.1 billion, with pre-tax profit rising 16% to £138.9 million and global staff numbers reaching 7,900 in its 24-year history.
Waste Not: How Ireland’s New Medicines Disposal Scheme Turns a €37.5 Million Problem into a Managed System
New RCSI research estimates Ireland generates over €37.5 million of unused and expired medicines annually. The forthcoming national DUMP scheme offers a practical infrastructure response to a problem that now has a peer-reviewed evidence base.
Women in Pharma Awards 2026 highlights video released following Crowne Plaza Santry gala
The Women in Pharma Awards 2026 highlights video is now available, capturing the ceremony and celebrations from the 29th April gala at the Crowne Plaza Hotel, Santry. The footage brings to life a landmark evening for Ireland's pharmaceutical community, featuring recognition ceremonies, award presentations, and networking moments from across the sector.
Brendan McGrath of WuXi Biologics Ireland Ltd to receive Outstanding Contribution Award at the Life Sciences Industry Awards 2026
Brendan McGrath of WuXi Biologics Ireland Ltd will receive the Outstanding Contribution Award at the Life Sciences Industry Awards 2026, recognised for leading the establishment and development of a state-of-the-art biopharmaceuticals manufacturing facility in Dundalk from the ground up.
Bristol Myers Squibb and Hengrui forge $15.2 billion early-stage drug alliance
US pharmaceutical giant Bristol Myers Squibb and Chinese biopharma company Hengrui Pharma have agreed one of the largest licensing and collaboration deals in pharmaceutical industry history, centring on 13 early-stage oncology, immunology, and haematology assets valued at up to $15.2 billion.
Isomorphic Labs raises $2.1 billion Series B to scale AI drug design engine and pipeline
UK-based AI drug design company Isomorphic Labs has secured $2.1 billion in Series B funding to accelerate its therapeutic pipeline and further develop its IsoDDE AI drug design engine across multiple therapeutic areas and drug modalities.
BioCryst licenses navenibart to Irish affiliate of Neopharmed Gentili for European HAE market
Biotechnology company BioCryst Pharmaceuticals has granted the Irish affiliate of Italian pharmaceutical company Neopharmed Gentili an exclusive European licence to commercialise navenibart for hereditary angioedema in a deal worth up to $345 million.
Evumed establishes European headquarters at Cork Airport Business Park with 30 new jobs
Cork-based biopharmaceutical company Evumed has announced a multi-million-euro investment at Cork Airport Business Park, establishing its European headquarters and creating 30 high-value jobs across quality, regulatory, supply chain, finance, and support functions in 2026.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
